Erping Luo Selected Research

Body Weight (Weight, Body)

5/2023	Electromagnetic fields ameliorate hepatic lipid accumulation and oxidative stress: potential role of CaMKKβ/AMPK/SREBP-1c and Nrf2 pathways.
1/2018	Pulsed electromagnetic fields (PEMF) attenuate changes in vertebral bone mass, architecture and strength in ovariectomized mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erping Luo Research Topics

Disease

8	Osteoporosis 01/2023 - 02/2010
7	Bone Resorption 01/2021 - 10/2014
4	Hypoxia (Hypoxemia) 03/2023 - 01/2021
4	Altitude Sickness (Mountain Sickness) 01/2023 - 08/2012
3	Metabolic Bone Diseases (Osteopenia) 01/2023 - 01/2020
3	Hyperglycemia 01/2018 - 01/2013
2	Wounds and Injuries (Trauma) 09/2023 - 12/2010
2	Body Weight (Weight, Body) 05/2023 - 01/2018
2	Neoplasms (Cancer) 08/2022 - 07/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2020 - 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2024
1	Hematoma 10/2022
1	Cerebral Hemorrhage 10/2022
1	Inflammation (Inflammations) 10/2022
1	Cognitive Dysfunction 01/2021
1	Fibrosis (Cirrhosis) 01/2020
1	Pathologic Constriction (Stenosis) 01/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Right Ventricular Hypertrophy 01/2020
1	Poisoning 04/2019
1	Brain Injuries (Brain Injury) 04/2019
1	Fatigue 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 07/2017
1	Neuroblastoma 01/2017
1	hypoglycemic encephalopathy 01/2017
1	Adenocarcinoma of Lung 09/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2016
1	Stroke (Strokes) 05/2015
1	Liver Failure 08/2014
1	Diabetes Mellitus 01/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2013
1	Weight Loss (Weight Reduction) 01/2013

Drug/Important Bio-Agent (IBA)

6	Oxygen (Dioxygen)IBA 01/2023 - 08/2012
3	Collagen Type I (Type I Collagen)IBA 01/2020 - 10/2014
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2016
2	Cathepsin KIBA 01/2021 - 01/2021
2	Estrogens (Estrogen)FDA Link 01/2021 - 01/2018
2	CytokinesIBA 01/2020 - 01/2020
2	Tartrate-Resistant Acid PhosphataseIBA 01/2018 - 10/2014
2	DNA (Deoxyribonucleic Acid)IBA 07/2017 - 06/2013
2	Streptozocin (Streptozotocin)FDA Link 01/2016 - 01/2013
1	CalciumIBA 01/2024
1	Parathyroid Hormone (Parathormone)IBA 09/2023
1	LipidsIBA 05/2023
1	Triglycerides (Triacylglycerol)IBA 05/2023
1	Keratin-18 (Keratin 18)IBA 03/2023
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2023
1	TRPP Cation ChannelsIBA 01/2023
1	Adenosine Monophosphate (AMP)IBA 01/2023
1	Calcium Channels (Calcium Channel)IBA 01/2023
1	GenisteinIBA 10/2022
1	Calcitonin Receptors (Calcitonin Receptor)IBA 01/2021
1	MelatoninIBA 10/2020
1	Angiotensin-Converting Enzyme 2IBA 01/2020
1	Angiotensin IIIBA 01/2020
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020
1	Endothelin-1 (Endothelin 1)IBA 01/2020
1	Collagen Type III (Type III Collagen)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Anabolic AgentsIBA 01/2020
1	hydrogen rich salineIBA 04/2019
1	Free RadicalsIBA 04/2019
1	Neuroprotective AgentsIBA 04/2019
1	Carbon MonoxideIBA 04/2019
1	CarboxyhemoglobinIBA 04/2019
1	SolutionsIBA 04/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	MineralsIBA 01/2018
1	CateninsIBA 01/2018
1	AlloxanIBA 01/2018
1	basic fuchsinIBA 01/2018
1	AlbuminsIBA 07/2017
1	Fetal Proteins (Fetoprotein)IBA 07/2017
1	pterostilbeneIBA 01/2017
1	lysyl- lysyl- leucyl- phenylalanyl- lysyl- lysyl- isoleucyl- leucyl- lysyl- tyrosyl- leucinamideIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Proteins (Proteins, Gene)FDA Link 09/2016
1	Gefitinib (Iressa)FDA Link 09/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 09/2016
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 09/2016
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 09/2016
1	Leptin ReceptorsIBA 01/2016
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2015
1	OsteocalcinIBA 10/2014
1	ProcollagenIBA 10/2014
1	GlucocorticoidsIBA 08/2014
1	OsteoprotegerinIBA 06/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Therapeutic UsesIBA 01/2013
1	NAD (NADH)IBA 01/2013

Therapy/Procedure

2	Therapeutics 10/2022 - 01/2016
1	Bed Rest (Bedrest) 01/2023
1	Radiotherapy 08/2022
1	Intraperitoneal Injections 04/2019
1	Radiofrequency Ablation 07/2017